Towards xenotransplantation of pig islets in the clinic

Current Opinion in Organ Transplantation

Volumn 16, Issue 2, 2011, Pages 195-200

  Elliott, Robert B ^a  

^a Living Cell Technologies Ltd   (New Zealand)

Author keywords

clinical trials; islets; xenotransplantation

Indexed keywords

ACUTE GRAFT REJECTION; ALLOTRANSPLANTATION; ARTICLE; CELL TRANSPLANTATION; CELL VIABILITY; DNA MODIFICATION; GENE EXPRESSION; GRAFT SURVIVAL; HUMAN; HYPOGLYCEMIA; INFECTION RISK; INSULIN DEPENDENT DIABETES MELLITUS; MICROENCAPSULATION; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PARKINSON DISEASE; SERTOLI CELL; SWINE; XENOTRANSPLANTATION;

ANIMALS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; RISK ASSESSMENT; RISK FACTORS; SWINE; TIME FACTORS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 79954578961     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283449dec     Document Type: Article

References (34)

1. Hering BJ, Walawalkar N. Pig to non human primate islet xenotransplantation. Transpl Immunol 2009; 21:81-86.
2. Schumacher JM, Ellias SA, Palmer EP, et al. Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 2000; 54:1042-1050. (Pubitemid 30151843)
3. Selawry HP, Kotb M, Herrod HG, Lu ZN. Production of a factor, or factors, suppressing IL-2 production and T cell proliferation by Sertoli cell-enriched preparations. A potential role for islet transplantation in an immunologically privileged site. Transplantation 1991; 52:846-850.
4. Yang H, Wright JR Jr. Co-encapsulation of Sertoli enriched testicular cell fractions further prolongs fish-to-mouse islet xenograft survival. Transplantation 1999; 67:815-820. (Pubitemid 29169125)
5. Valdés-González RA, Dorantes LM, Garibay GN, et al. Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4 year study. Eur J Endocrinol 2005;153:419-427. (Pubitemid 41410499)
6. Suarez-Pinzon W, Korbutt GS, Power R, et al. Testicular Sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism. Diabetes 2000; 49:1810-1818.
7. Van Vlasselaer P, Vandeputte M. Suppression of cellular immune reactions by rat ovarian cells. Transplantation 1985; 39:541-547. (Pubitemid 15036457)
8. Thanos CG, Elliott RB. Encapsulated porcine islet transplantation: an evolving therapy for the treatment of type I diabetes. Expert Opin Biol Ther 2009; 9:29-44.
9. Sun Y, Ma X, Zhou D, et al. Normalization of diabetes in spontaneously diabetic cynomolgus monkeys by xenografts of microencapsulated porcine islets without immuno-suppression. J Clin Invest 1996; 98:1417-1422. (Pubitemid 26322067)
10. Elliott RB, Escobar L, Tan PL, et al. Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates. Transplant Proc 2005; 37:3505-3508. (Pubitemid 41659935)
11. Dufrane D, Goebbels RM, Gianello P. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to six months without immunosuppression. Transplantation 2006; 81:1345-1353.
12. Dai Y, Vaught TD, Boone J, et al. Targeted disruption of the alpha1,3- galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002; 20:251-255. (Pubitemid 34205417)
13. Koike C, Kannagi R, Takuma Y, et al. Introduction of alpha (1,2)-fucosyltransferase and its effect on alpha-Gal epitopes in transgenic pig. Xenotransplantation 1996; 3:81-86. (Pubitemid 126559397)
14. Miyagawa S, Murakami H, Takahagi Y, et al. Remodeling of the major pig xenoantigen by N-acetyl-glucosaminyltransferase III in transgenic pigs. J Biol Chem 2001; 276:39310-39319.
15. Diamond LE, Quinn CM, Martin MJ, et al. A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation 2001; 71:132-142. (Pubitemid 32105790)
16. Langford GA, Yannoutsos N, Cozzi E, et al. Production of pigs transgenic for human decay accelerating factor. Transplant Proc 1994; 26:1400-1401. (Pubitemid 24211570)
17. Fodor WL, Williams BL, Matis LA, et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyper-acute organ rejection. Proc Natl Acad Sci USA 1994; 91:11153-11157. (Pubitemid 24349644)
18. Apice AJ, Cowan PJ. Xenotransplantation: the next generation of engineered animals. Transpl Immunol 2009; 21:111-115.
19. Huang SY, Chen YH, Teng SH, et al. Protein expression of lymphocytes in HLA-DR transgenic pigs by a proteomic approach. Proteomics 2006; 6:5815-5825.
20. Esker B, Cooper DK. Overcoming the barriers to xenotransplantation: prospects for the future. Expert Rev Clin Immunol 2010; 6:219-230.
21. Londrigan SL, Sutherland RM, Brady JL, et al. In situ protection against islet allograft rejection by CTLA4Ig transduction. Transplantation 2010; 90:951-957.
22. Dufrane D, Gianello P. Pig islet xenotransplantation into nonhuman primate model. Transplantation 2008; 86:753-760.
23. Bennett W, Bjorkland A, Sundberg B, et al. A comparison of fetal and adult porcine islets with regard to Gal alpha (1,3)Gal expression and the role of human immunoglobulins and complement in islet cell cytotoxicity. Transplantation 2000; 69:L1711-L1717.
24. Pappas KK, Colton CK, Qipo A, et al. Prediction of marginal mass required for successful islet transplantation. J Invest Surg 2010; 23:28-34.
25. Van Deijnen JH, Hulstaert CE, Wolters GH, van Schilfgaarde R. Significance of the peri-insular extracellular matrix for islet isolation from the pancreas of rat, dog, pig and man. Cell Tissue Res 1992; 267:139-146.
26. Mythili DM, Patra SS, Gunasekaran S. Culture prior to transplantation preserves the ultrastructural integrity of monkey pancreatic islets. J Electron Microsc (Tokyo) 2003; 52:399-405. (Pubitemid 37261367)
27. Ryan EA, Lakey JR, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with Edmond protocol. Diabetes 2001; 50:710-719. (Pubitemid 32242625)
28. Paradis K, Langford G, Long Z, et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 1999; 285:1236-1241. (Pubitemid 29398604)
29. Specke V, Plesker R, Wood J, et al. No in vivo infection of triple immunosuppressed nonhuman primates after inoculation with high titers of porcine endogenous retroviruses. Xenotransplantation 2009; 16:34-44
30. DRAFT Report of the Biological Response Modifiers Advisory; Food and Drug Administration Centre for Biologics Evaluation and Research; Subcommittee on Xenotransplantation; Meeting of June 3 and 4, 1999.
31. Kin T, Rosichuk S, Shapiro AM, Lakey JR. Detection of microbial contamination during human islet isolation. Cell Transplant 2007; 16:9-13. (Pubitemid 46516653)
32. Xenotransplantation Trials in NZ, National Health Committee; www.nhc.health. govt.nz.
33. Leitao CB, Tharavanij T, Cure P, et al. Restoration of hypoglycaemia awareness after islet transplantation. Diabetes Care 2008; 31:5.
34. Garkavenko O, Wynyard S, Nathu D, et al. Porcine endogenous retrovirus transmission characteristics from a designated pathogen-free herd. Transplant Proc 2008; 40:590-593. (Pubitemid 351419220)